Gene · 406909
Papers2,249
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,249
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunotherapy in patients with brain metastasis: advances and challenges for the treatment and the application of circulating biomarkers. | Front Immunol | 2023 | 38022574 | PubTator, text mining | PubMed |
| Exosomal non-coding RNAs in glioma progression: insights into tumor microenvironment dynamics and therapeutic implications. | Front Cell Dev Biol | 2023 | 38020906 | PubTator, text mining | PubMed |
Genome editing approaches with CRISPR/Cas9: the association of NOX4 expression in breast cancer patients and effectiveness evaluation of different strategies of CRISPR/Cas9 to knockout Nox4 in cancer cells. | BMC Cancer | 2023 | 38012557 | PubTator, text mining | PubMed |
Construction of an Exudative Age-Related Macular Degeneration Diagnostic and Therapeutic Molecular Network Using Multi-Layer Network Analysis, a Fuzzy Logic Model, and Deep Learning Techniques: Are Retinal and Brain Neurodegenerative Disorders Related? | Pharmaceuticals (Basel) | 2023 | 38004422 | PubTator, text mining | PubMed |
| Characterization of a miRNA Signature with Enhanced Diagnostic and Prognostic Power for Patients with Bladder Carcinoma. | Int J Mol Sci | 2023 | 38003433 | PubTator, text mining | PubMed |
| Strain Variation Can Significantly Modulate the miRNA Response to Zika Virus Infection. | Int J Mol Sci | 2023 | 38003407 | PubTator, text mining | PubMed |
| Small RNA Sequencing Reveals a Distinct MicroRNA Signature between Glucocorticoid Responder and Glucocorticoid Non-Responder Primary Human Trabecular Meshwork Cells after Dexamethasone Treatment. | Genes (Basel) | 2023 | 38002955 | PubTator, text mining | PubMed |
| PanomiR: a systems biology framework for analysis of multi-pathway targeting by miRNAs. | Brief Bioinform | 2023 | 37985452 | PubTator, text mining | PubMed |
| Exosomes drive ferroptosis by stimulating iron accumulation to inhibit bacterial infection in crustaceans. | J Biol Chem | 2023 | 37977221 | PubTator, text mining | PubMed |
| Fgf2 and Ptpn11 play a role in cerebral injury caused by sevoflurane anesthesia. | Medicine (Baltimore) | 2023 | 37960778 | PubTator, text mining | PubMed |
| miRNAs: Targets to Investigate Herpesvirus Infection Associated with Neurological Disorders. | Int J Mol Sci | 2023 | 37958855 | PubTator, text mining | PubMed |
| Application and underlying mechanism of acupuncture for the nerve repair after peripheral nerve injury: remodeling of nerve system. | Front Cell Neurosci | 2023 | 37941605 | PubTator, text mining | PubMed |
| Interplay between lncRNA RP11-367G18.1 variant 2 and YY1 plays a vital role in hypoxia-mediated gene expression and tumorigenesis. | Cancer Cell Int | 2023 | 37941005 | PubTator, text mining | PubMed |
| Crucial Role of microRNAs as New Targets for Amelogenesis Disorders Detection. | Curr Drug Targets | 2023 | 37936447 | PubTator, text mining | PubMed |
| Precision medicine in nasopharyngeal carcinoma: comprehensive review of past, present, and future prospect. | J Transl Med | 2023 | 37932756 | PubTator, text mining | PubMed |
| Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome. | Front Endocrinol (Lausanne) | 2023 | 37929034 | PubTator, text mining | PubMed |
| SGMS1-AS1/MicroRNA-106a-5p/CPT2 Axis as a Novel Target for Regulating Lactate Metabolism in Colon Cancer. | Technol Cancer Res Treat | 2023 | 37926998 | PubTator, text mining | PubMed |
| USP14 predicts poorer survival outcomes and promotes tumor progression in endometrial carcinoma by activating NF-κB signaling. | Aging (Albany NY) | 2023 | 37917013 | PubTator, text mining | PubMed |
| Insight into extracellular vesicles in vascular diseases: intercellular communication role and clinical application potential. | Cell Commun Signal | 2023 | 37907962 | PubTator, text mining | PubMed |
| Advances in the study of exosome-derived miRNAs in the pathogenesis, diagnosis, and treatment of systemic lupus erythematosus. | Lupus | 2023 | 37906972 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406909/papers?page=13